Curriculum · Screening (National/International)
Levels of prevention and population-appropriate screening
What it is
Prevention is named at more than one level. Primary prevention acts on the source of the harm before disease has occurred, and the lead example carries the point: the most reliable and cost-effective way to protect children from lead toxicity is primary prevention, which means reducing or eliminating the sources of lead in the community. Measures that come later do less. Checking serum lead levels after exposures, anticipatory guidance about hand washing or dust control, iron and calcium supplementation, and providing cleaning equipment have been shown to have little or no effect, or else they address high lead levels only after the lead poisoning has already occurred. Secondary prevention is named alongside primary where one treatment serves both, since statins are useful for the primary and for the secondary prevention of cardiovascular disease, with the greater benefit where the baseline risk is greater.
How it is treated
Low-dose aspirin is recommended for the primary prevention of cardiovascular disease in patients 50 to 59 years of age whose risk of cardiovascular disease is 10% or more. The same recommendation adds that the patient should have a life expectancy of at least 10 years, should be willing to take daily aspirin for at least 10 years, and should not be at increased risk for gastrointestinal bleeding. For patients 60 to 69 years of age the decision to start aspirin rests on individual considerations, and for adults younger than 50 or age 70 and older the evidence is insufficient to weigh benefits against harms. A trial of daily aspirin in those over age 70 found that it did not significantly lower the risk of cardiovascular disease and did not increase disability-free survival. Physical activity carries its own numbers: the most active people had median cardiovascular risk reductions of about 30% to 35% when set against the least active. Statin therapy would not be supported by current guidelines where the 10-year risk of atherosclerotic cardiovascular disease is under 5%. Fish oil supplements have not proven useful for primary prevention, and niacin is no longer recommended for cardiovascular risk reduction.